Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-127179
Filing Date
2020-04-30
Accepted
2020-04-29 20:59:59
Documents
117
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d879645d20f.htm 20-F 1632501
2 EX-1.1 d879645dex11.htm EX-1.1 488619
3 EX-1.2 d879645dex12.htm EX-1.2 206389
4 EX-4.4 d879645dex44.htm EX-4.4 79754
5 EX-8.1 d879645dex81.htm EX-8.1 1929
6 EX-12.1 d879645dex121.htm EX-12.1 10637
7 EX-12.2 d879645dex122.htm EX-12.2 10259
8 EX-13.1 d879645dex131.htm EX-13.1 5642
9 EX-15.1 d879645dex151.htm EX-15.1 4794
16 GRAPHIC g879645g0428124505003.jpg GRAPHIC 2219
17 GRAPHIC g879645g27k26.jpg GRAPHIC 9132
18 GRAPHIC g879645g50t99.jpg GRAPHIC 2345
19 GRAPHIC g879645g84g14.jpg GRAPHIC 2480
20 GRAPHIC g879645g85f55.jpg GRAPHIC 8226
21 GRAPHIC g879645g92b99.jpg GRAPHIC 2538
22 GRAPHIC g879645g99y49.jpg GRAPHIC 1053
23 GRAPHIC g879645gra0016.jpg GRAPHIC 8293
24 GRAPHIC g879645gra0016c.jpg GRAPHIC 9316
25 GRAPHIC g879645gra042.jpg GRAPHIC 8176
26 GRAPHIC g879645sp69.jpg GRAPHIC 1006
  Complete submission text file 0001193125-20-127179.txt   8432282

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT corv-20191231.xml EX-101.INS 1542319
11 XBRL TAXONOMY EXTENSION SCHEMA corv-20191231.xsd EX-101.SCH 67034
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE corv-20191231_cal.xml EX-101.CAL 61303
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE corv-20191231_def.xml EX-101.DEF 387210
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE corv-20191231_lab.xml EX-101.LAB 511566
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE corv-20191231_pre.xml EX-101.PRE 475654
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-29338 | Film No.: 20832813
SIC: 2834 Pharmaceutical Preparations